Search Results

There are 5737 results for: content related to: In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time

  1. Dalteparin dose-dependently increases ROTEM® thrombelastography parameters only at supratherapeutic anti-factor Xa levels: An in vitro study

    Clinical and Experimental Pharmacology and Physiology

    Volume 38, Issue 11, November 2011, Pages: 783–786, Martin Feuring, Martin Wehling and Armin Schultz

    Version of Record online : 20 OCT 2011, DOI: 10.1111/j.1440-1681.2011.05593.x

  2. Safety of Outpatient Dalteparin Therapy in Veterans with Mechanical Heart Valves

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 11, November 2005, Pages: 1560–1565, Jessica L. O'Neill, Petra S. Flanagan, Carolyn R. Zaleon and Laurel A. Copeland

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.11.1560

  3. You have free access to this content
    Treatment of upper-extremity deep vein thrombosis

    Journal of Thrombosis and Haemostasis

    Volume 9, Issue 10, October 2011, Pages: 1924–1930, S. W. RATHBUN, J. A. STONER and T. L. WHITSETT

    Version of Record online : 29 SEP 2011, DOI: 10.1111/j.1538-7836.2011.04466.x

  4. Life-Threatening Hemorrhage After Dalteparin Therapy in a Patient with Impaired Renal Function

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 6, June 2005, Pages: 881–885, Ms. Sabin S. Egger, Dr. Mikael G. Sawatzki, Dr. Jürgen Drewe and Dr. Stephan Krähenbühl

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.6.881

  5. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: P0001–P2386,

    Version of Record online : 9 SEP 2013, DOI: 10.1111/j.1538-7836.2005.0300c.x

  6. You have free access to this content
    A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis

    Journal of Thrombosis and Haemostasis

    Volume 10, Issue 5, May 2012, Pages: 833–839, S. W. RATHBUN, C. E. ASTON and T. L. WHITSETT

    Version of Record online : 2 MAY 2012, DOI: 10.1111/j.1538-7836.2012.04669.x

  7. You have free access to this content
    Abstracts

    Journal of Thrombosis and Haemostasis

    Volume 3, Issue s1, August 2005, Pages: H01–SYM90,

    Version of Record online : 6 SEP 2013, DOI: 10.1111/j.1538-7836.2005.03000.x

  8. You have free access to this content
    The low-molecular-weight heparin dalteparin as adjuvant therapy in acute myocardial infarction: The ASSENT PLUS study

    Clinical Cardiology

    Volume 24, Issue S1, March 2001, Pages: 12–14, Lars Wallentin, B. Lindahl, M. Dellborg, T. Nilsson, K. Pehrsson and E. Swahn

    Version of Record online : 3 FEB 2009, DOI: 10.1002/clc.4960241305

  9. You have free access to this content
    Investment in prolonged thromboprophylaxis with dalteparin improves clinical outcomes after hip replacement

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue 5, May 2003, Pages: 896–906, O. E. Dahl and A. M. Pleil

    Version of Record online : 25 APR 2003, DOI: 10.1046/j.1538-7836.2003.00236.x

  10. Clinical experience of anti-Xa monitoring in critically ill dogs receiving dalteparin

    Journal of Veterinary Emergency and Critical Care

    Volume 24, Issue 4, July/August 2014, Pages: 421–428, Alex M. Lynch, Armelle M. deLaforcade and Claire R. Sharp

    Version of Record online : 22 AUG 2014, DOI: 10.1111/vec.12206

  11. You have free access to this content
    Influence of prolonged dalteparin treatment on coagulation, fibrinolysis and inflammation in unstable coronary artery disease

    Journal of Internal Medicine

    Volume 258, Issue 5, November 2005, Pages: 420–427, J. OLDGREN, C. FELLENIUS, K. BOMAN, J.-H. JANSSON, T. K. NILSSON, L. WALLENTIN and A. SIEGBAHN

    Version of Record online : 17 OCT 2005, DOI: 10.1111/j.1365-2796.2005.01562.x

  12. You have full text access to this OnlineOpen article
    Dalteparin, a low-molecular-weight heparin, promotes angiogenesis mediated by heparin-binding VEGF-A in vivo

    APMIS

    Volume 118, Issue 12, December 2010, Pages: 949–957, KLAS NORRBY and ARVID NORDENHEM

    Version of Record online : 12 OCT 2010, DOI: 10.1111/j.1600-0463.2010.02635.x

  13. You have free access to this content
    A randomized, controlled, dose-guiding study of the oral direct thrombin inhibitor ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis: THRIVE I

    Journal of Thrombosis and Haemostasis

    Volume 1, Issue 1, January 2003, Pages: 41–47, H. Eriksson, K. Wåhlander, D. Gustafsson, L.t Welin, L. Frison, S. Schulman and for the thrive investigators

    Version of Record online : 3 JAN 2003, DOI: 10.1046/j.1538-7836.2003.00034.x

  14. You have free access to this content
    A critical review of clinical trials for low-molecular-weight heparin therapy in unstable coronary artery disease

    Clinical Cardiology

    Volume 24, Issue 7, July 2001, Pages: 492–499, Steen Husted, Richard Becker and Andre Kher

    Version of Record online : 3 FEB 2009, DOI: 10.1002/clc.4960240715

  15. Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy

    Pediatric Blood & Cancer

    Volume 55, Issue 6, 1 December 2010, Pages: 1118–1125, Hirotoshi Sakaguchi, Nobuhiro Watanabe, Hideki Muramatsu, Sayoko Doisaki, Nao Yoshida, Kimikazu Matsumoto and Koji Kato

    Version of Record online : 29 JUN 2010, DOI: 10.1002/pbc.22645

  16. You have free access to this content
    Improving outcomes in acute coronary syndromes—The FRISCII trial

    Clinical Cardiology

    Volume 24, Issue S1, March 2001, Pages: 3–7, Frederic Kontny

    Version of Record online : 3 FEB 2009, DOI: 10.1002/clc.4960241303

  17. You have free access to this content
    Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

    Journal of Thrombosis and Haemostasis

    Volume 7, Issue 1, January 2009, Pages: 58–64, E. REY, P. GARNEAU, M. DAVID, R. GAUTHIER, L. LEDUC, N. MICHON, F. MORIN, C. DEMERS, S. R. KAHN, L. A. MAGEE and M. RODGER

    Version of Record online : 20 NOV 2008, DOI: 10.1111/j.1538-7836.2008.03230.x

  18. A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis

    Journal of Internal Medicine

    Volume 240, Issue 2, August 1996, Pages: 85–92, K. LUOMANMÄKI, S. GRANKVIST, C. HALLERT, I. JAURO, K. KETOLA, H. C. KIM, H. KIVINIEMI, H. KOSKIVIRTA, L. SÖRSKOG and P. VILKKO

    Version of Record online : 31 OCT 2003, DOI: 10.1046/j.1365-2796.1996.18845000.x

  19. You have free access to this content
    Key Articles and Guidelines for the Prevention of Venous Thromboembolism

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 4, April 2009, Pages: 410–458, Dr. Paul P. Dobesh, Dr. Ann K. Wittkowsky, Dr. Zachary Stacy, Dr. William E. Dager, Dr. Stuart T. Haines, Dr. Larry M. Lopez, Dr. Edith Nutescu, Dr. Katherine W. Phillips, Dr. Toby C. Trujillo and Dr. Tom Vondracek

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.4.410

  20. You have free access to this content
    Treatment of venous thromboembolism in cancer patients with dalteparin for up to 12 months: the DALTECAN Study

    Journal of Thrombosis and Haemostasis

    Volume 13, Issue 6, June 2015, Pages: 1028–1035, C. W. Francis, C. M. Kessler, S. Z. Goldhaber, M. J. Kovacs, M. Monreal, M. V. Huisman, D. Bergqvist, A. G. Turpie, T. L. Ortel, A. C. Spyropoulos, I. Pabinger and A. K. Kakkar

    Version of Record online : 10 MAY 2015, DOI: 10.1111/jth.12923